Overview

Company Profile

MYOS RENS is an emerging BioNutrition company focused on the discovery, development and commercialization of advanced nutrition products that improve muscle health and function.

View Detailed Stock Data

Stock Snapshot

MYOS Symbol
Nasdaq Market
Market Cap
Price
Change
Volume
View IR Calendar

Events

MYOS RENS Announces Study Results Demonstrating Fortetropin® Prevents Muscle Loss in Canines After Surgery and Enhances Recovery

Archived & available for 2 wks after the call. Digital webcast replay thru 4/15/19; dial 877-660-6853 US, 201-612-7415 Int’l; conf ID #13686568

Conference ID#: 13686568

Webcast

View Press Releases

Recent News

MYOS RENS Technology Announces First Endorsement Deal for Yolked® with NBA Superstar Aaron Gordon
MYOS CEO Joseph Mannello Issues Letter to Shareholders Following Presentation at North American Veterinary Community (NAVC) Conference/VMX
MYOS RENS Technology Announces Study Results Demonstrating Fortetropin®, the Active Ingredient in Myos Canine Muscle Formula, Prevents Muscle Loss in Canines After Surgery and Enhances Recovery